Transferrin dipstick as a potential novel test for colon cancer screening: A comparative study with immuno fecal occult blood test

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 8, 2009, Pages 2182-2185

  Sheng, Jian Qiu ^a   Li, Shi Rong ^a   Wu, Zi Tao ^a   Xia, Chang Hong ^a   Wu, Xia ^a   Chen, Jigui ^b   Rao, Jianyu ^c,d  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Eight Hospital   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFERRIN;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; COLON ADENOMA; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY; TRANSFERRIN; TUMOR MARKERS, BIOLOGICAL;

EID: 68949128854     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0309     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Anderson F, Guyton Z, Hiatt A, Vernon SW, Levin B, Hawk E. Colorectal cancer screening for persons at average risk. J Natl Cancer Inst 2002;94:1126-33.
3. Wilkins T, Reynolds PL. Colorectal cancer: A summary of the evidence for screening and prevention. Am Fam Physician 2008;78:1385-92.
4. Mikhailova E, Pimanov S, Voropaev E. Fecal oncomarkers in the diagnostics of colorectal cancer. Klin Med (Mosk) 2007;85:62-7.
5. Lohsiriwat V, Thavichaigarn P, Awapittaya B. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection. J Med Assoc Thai 2007;90:2291-5.
6. Xie T, Wu M, Sheng F, et al. Changes of transferrin receptor and asialoglycoprotein receptor in hepatoma cell membrane. Acad J Second Military Med Univ 1997;18:6-8.
7. Chiang C, Jeng J, Wang W, Jheng B, Hsu W, Chen B. A comparative study of three fecal occult blood tests in upper gastrointestinal bleeding. Kaohsiung J Med Sci 2006;22:223-8.
8. Yang M, Cong Y, Zhang Z, Dia C, Kong S, Cheng L. Simultaneous determination of both transferrin and hemoglobin in the patient with digestive tract bleeding. Chin J Clin Lab Sci 2003;21:83-4.
9. Saldova R, Wormald M, Dwek R, Rudd P. Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis. Dis Markers 2008;25:219-32.
10. Ward D, Suggett N, Cheng Y, et al. Identification of serum biomarkers for colon cancer by proteomic analysis. Br J Cancer 2006;19;94: 1898-905.
11. Ahmed N, Oliva K, Barker G, et al. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer. Proteomics 2005;5:4625-36.
12. Mandel J, Bond J, Church T, et al. Reducing mortality for colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328: 1365-71.
13. Hardcastle J, Thomas W, Chamberlain J, et al. Randomised, controlled trial of faecal occult blood screening for colorectal cancer: results for first 107,349 subjects. Lancet 1989;1:1160-4.
14. Li S, Wang H, Hu J, et al. New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: results of a prospective multicenter study in Chinese patients. Int J Cancer 2006;118: 3078-83.
15. Li S. Early diagnosis of colorectal cancers. In: Li SR, editor. Early diagnosis, treatment and prevention of colorectal cancers. Beijing: Science Press; 2000. p. 140-80.
16. Ahlquist D, Shuber A. Stool screening for colorectal cancer: evolution from occult blood to molecular markers. Clin Chim Acta 2002;315: 157-68.
17. Li S, Zhang C, Xu E. Supplementary value of fecal sequential occult blood test and microalbumin on improvement of the screening rate of colorectal tumors. Chin J Oncol 1995;17:381-3.
18. Mizuno M, NakagawaM, Uesu T, et al. Detection of decay-accelerating factor in stool specimens of patients with colorectal cancer. Gastroenterology 1995;109:826-31.
19. Kronborg O, Ugstad M, Fuglerud P, et al. Faecal calprotectin levels in a high risk population for colorectal neoplasia. Gut 2000;46:795-800.
20. Kim Y, Lee S, Park S, et al. Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen. Ann Clin Lab Sci 2003;33:32-8.